bg
P

Phathom Pharma (PHAT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Phathom Pharma (PHAT)

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more

  • USD11.90
  • USD11.97
  • USD11.31
  • USD19.71
  • 14.10%
  • 114M
  • 570.56k
  • 1.14M
  • 840M
  • 2.21
  • -39.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.